The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
scFv Antibody: Principles and Clinical Application
Open accessAbstract
To date, generation of single-chain fragment variable (scFv) has become an established technique used to produce a completely functional antigen-binding fragment in bacterial systems. The advances in antibody engineering have now facilitated a more efficient and generally applicable method to produce Fv fragments. Basically, scFv antibodies produced from phage display can be genetically fused to the marker proteins, such as fluorescent proteins or alkaline phosphatase. These bifunctional proteins having both antigen-binding capacity and marker activity can be obtained from transformed bacteria and used for one-step immunodetection of biological agents. Alternatively, antibody fragments could also be applied in the construction of immunotoxins, therapeutic gene delivery, and anticancer intrabodies for therapeutic purposes. This paper provides an overview of the current studies on the principle, generation, and application of scFv. The potential of scFv in breast cancer research is also discussed in this paper.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension
Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90359-4 · Cited by 3,017
Phage antibodies: filamentous phage displaying antibody variable domains
McCafferty, J., Griffiths, A. D., Winter, G., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,423
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Marks, J. D., Hoogenboom, H. R., Bonnert, T. P., McCafferty, J., Griffiths, A. D., & Winter, G. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90498-u · Cited by 1,603
Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotný, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., & Crea, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5879 · Cited by 1,593
Making antibodies by phage display technology
Winter, G., Griffiths, A. D., Hawkins, R. E., & Hoogenboom, H. R. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002245 · Cited by 1,573
Single-Chain Antigen-Binding Proteins
Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S.-M., Lee, T., Pope, S. H., Riordan, G. S., & Whitlow, M. (1988) · Science · doi:10.1126/science.3140379 · Cited by 1,502
Recombinant protein expression in Escherichia coli
Baneyx, F. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00003-8 · Cited by 1,481
Making antibody fragments using phage display libraries
Clackson, T., Hoogenboom, H. R., Griffiths, A. D., & Winter, G. (1991) · Nature · doi:10.1038/352624a0 · Cited by 1,203
Certolizumab Pegol for the Treatment of Crohn's Disease
Sandborn, W. J., Feagan, B. G., Stoinov, S., Honiball, P. J., Rutgeerts, P., Mason, D., Bloomfield, R., & Schreiber, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067594 · Cited by 1,143
In vitro selection and evolution of functional proteins by using ribosome display
Hanes, J., & Plückthun, A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4937 · Cited by 1,088
Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., & Johnson, K. S. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-309 · Cited by 1,027
Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chiswell, D. J., Hudson, P., & Winter, G. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4133 · Cited by 1,020
Assembly of a Functional Immunoglobulin F v Fragment in Escherichia coli
Skerra, A., & Plückthun, A. (1988) · Science · doi:10.1126/science.3285470 · Cited by 978
Isolation of high affinity human antibodies directly from large synthetic repertoires.
Griffiths, A. D., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., Kontermann, R. E., Jones, P. T., Low, N. M., & Allison, T. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06626.x · Cited by 962
Improving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
Yokota, T., Milenic, D. E., Whitlow, M. D., & Schlom, J. (1992) · PubMed · Cited by 819
Knappik, A., Ge, L., Honegger, A., Pack, P., Fischer, M., Wellnhofer, G., Hoess, A., Wölle, J., Plückthun, A., & Virnekäs, B. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3444 · Cited by 728
Herceptin acts as an anti-angiogenic cocktail
Izumi, Y., Xu, L., di Tomaso, E., Fukumura, D., & Jain, R. K. (2002) · Nature · doi:10.1038/416279b · Cited by 623
Escherichia coli Secretion of an Active Chimeric Antibody Fragment
Better, M., Chang, C. P., Robinson, R. R., & Horwitz, A. H. (1988) · Science · doi:10.1126/science.3285471 · Cited by 579
Antibody phage display technology and its applications
Hoogenboom, H. R., de Bruı̈ne, A. P., Hufton, S. E., Hoet, R. M., Arends, J.-W., & Roovers, R. C. (1998) · Immunotechnology · doi:10.1016/s1380-2933(98)00007-4 · Cited by 512
Human anti-self antibodies with high specificity from phage display libraries.
Griffiths, A. D., Malmqvist, M., Marks, J. D., Bye, J. M., Embleton, M. J., McCafferty, J., Baier, M., Holliger, K. P., Gorick, B. D., & Hughes-Jones, N. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05706.x · Cited by 478
A comparison of strategies to stabilize immunoglobulin Fv-fragments
Glockshuber, R., Malia, M., Pfitzinger, I., & Plueckthun, A. (1990) · Biochemistry · doi:10.1021/bi00458a002 · Cited by 473
Somatic hypermutagenesis in immunoglobulin genes
Rogozin, I. B., & Kolchanov, N. A. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90134-l · Cited by 454
Sheets, M. D., Amersdorfer, P., Finnern, R., Sargent, P., Lindqvist, E., Schier, R., Hemingsen, G., Wong, C., Gerhart, J. C., & Marks, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6157 · Cited by 438
Advances in Escherichia coli production of therapeutic proteins
Swartz, J. R. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00199-3 · Cited by 429
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
Chaudhary, V. K., Queen, G., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., & Pastan, I. (1989) · Nature · doi:10.1038/339394a0 · Cited by 413
Kang, A. S., Barbas, C. F., Janda, K. D., Benkovic, S. J., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4363 · Cited by 411
Hudson, P. J., & Souriau, C. (2003) · Nature Medicine · doi:10.1038/nm0103-129 · Cited by 398
Hanes, J., Schaffitzel, C., Knappik, A., & Plückthun, A. (2000) · Nature Biotechnology · doi:10.1038/82407 · Cited by 373
Argos, P. (1990) · Journal of Molecular Biology · doi:10.1016/0022-2836(90)90085-z · Cited by 334
New protein engineering approaches to multivalent and bispecific antibody fragments
Plückthun, A., & Pack, P. (1997) · Immunotechnology · doi:10.1016/s1380-2933(97)00067-5 · Cited by 322
Targeted therapy of cancer with radiolabeled antibodies.
Goldenberg, D. M. (2002) · PubMed · Cited by 318
An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability
Whitlow, M., Bell, B. A., Feng, S.-L., Filpula, D., Hardman, K. D., Hubert, S. L., Rollence, M. L., Wood, J. F., Schott, M. E., Milenic, D. E., et al. (1993) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/6.8.989 · Cited by 318
Gram, H., Marconi, L. A., Barbas, C. F., Collet, T. A., Lerner, R. A., & Kang, A. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3576 · Cited by 307
Schier, R., Bye, J., Apell, G., McCall, A., Adams, G. P., Malmqvist, M., Weiner, L. M., & Marks, J. D. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0004 · Cited by 292
Liu, S. Y., Eary, J. F., Petersdorf, S. H., Martin, P. J., Maloney, D. G., Appelbaum, F. R., Matthews, D. C., Bush, S. A., Durack, L. D., Fisher, D. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3270 · Cited by 286
Biopanning and rapid analysis of selective interactive ligands
Giordano, R. J., Cardó‐Vila, M., Lahdenranta, J., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1249 · Cited by 276
Antibody engineering: Comparison of bacterial, yeast, insect and mammalian expression systems
Verma, R., Boleti, E., & George, A. J. T. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00077-5 · Cited by 265
Strategies for selection of antibodies by phage display
Griffiths, A. D., & Duncan, A. R. (1998) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(98)80092-x · Cited by 250
Nieba, L., Honegger, A., Krebber, C., & Pluckthun, A. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.4.435 · Cited by 248
Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy
Chari, R. V. J. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00095-1 · Cited by 235
Chowdhury, P. S., Viner, J. L., Beers, R., & Pastan, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.669 · Cited by 222
High avidity scFv multimers; diabodies and triabodies
Hudson, P. J., & Kortt, A. A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00157-x · Cited by 219
[3] Protein engineering of single-chain Fv analogs and fusion proteins
Huston, J. S., Mudgett-Hunter, M., Tai, M.-S., McCartney, J., Warren, F., Haber, E., & Oppermann, H. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)03005-2 · Cited by 215
Natural and designer binding sites made by phage display technology
Hoogenboom, H. R., & Chames, P. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01667-4 · Cited by 213
Selection for a periplasmic factor improving phage display and functional periplasmic expression
Bothmann, H., & Plückthun, A. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-376 · Cited by 201
The Periplasmic Escherichia coli Peptidylprolyl cis,trans-Isomerase FkpA
Bothmann, H., & Plückthun, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910233199 · Cited by 192
M. Cardarelli, M. Q. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-001-0247-1 · Cited by 189
Isolation of anti-CD22 Fv with high affinity by Fv display on human cells
Ho, M., Nagata, S., & Pastan, I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603653103 · Cited by 179
High-Throughput Proteomics: Protein Expression and Purification in the Postgenomic World
Lesley, S. A. (2001) · Protein Expression and Purification · doi:10.1006/prep.2001.1465 · Cited by 171
Recombinant antibody constructs in cancer therapy
Hudson, P. J. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00013-8 · Cited by 169
Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli.
Cabilly, S., Riggs, A. D., Pande, H., Shively, J. E., Holmes, W. E., Rey, M., Perry, L. J., Wetzel, R., & Heyneker, H. L. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3273 · Cited by 168
Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised in E. coli
Boss, M. A., Kenten, J. H., Wood, C. R., & Emtage, J. S. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.9.3791 · Cited by 168
Chlebowski, R. T., Collyar, D. E., Somerfield, M. R., & Pfister, D. G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1939 · Cited by 164
Alvarez, R. D., Barnes, M. N., Gómez-Navarro, J., Wang, M., Strong, T. V., Arafat, W. O., Arani, R. B., Johnson, M. R., Roberts, B. L., Siegal, G. P., et al. (2000) · PubMed · Cited by 161
Of mice and men: hybridoma and recombinant antibodies
Little, M., Kipriyanov, S. M., Gall, F. L., & Moldenhauer, G. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01668-6 · Cited by 160
Single chain Fab (scFab) fragment
Hust, M., Jostock, T., Menzel, C., Voedisch, B., Mohr, A., Brenneis, M., Kirsch, M. I., Meier, D., & Dübel, S. (2007) · BMC Biotechnology · doi:10.1186/1472-6750-7-14 · Cited by 156
Chaudhary, V. K., Batra, J. K., Gallo, M. G., Willingham, M. C., FitzGerald, D. J., & Pastan, I. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1066 · Cited by 154
McWhirter, J. R., Kretz-Rommel, A., Saven, A., Maruyama, T., Potter, K. N., Mockridge, C. I., Ravey, E. P., Qin, F., & Bowdish, K. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510081103 · Cited by 154
Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher, D. M., Pavlínková, G., Beresford, G., Booth, B. J. M., Choudhury, A., & Batra, S. K. (1998) · PubMed · Cited by 143
The Periplasmic Escherichia coli Peptidylprolyl cis,trans-Isomerase FkpA
Ramm, K., & Plückthun, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910234199 · Cited by 141
Therapeutic Antibodies: Current State and Future Trends – Is a Paradigm Change Coming Soon?
Dimitrov, D. S., & Marks, J. D. (2009) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-554-1_1 · Cited by 132
Gura, T. (2002) · Nature · doi:10.1038/417584a · Cited by 131
Wörn, A., & Plückthun, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00463-3 · Cited by 125
Forrer, P., Jung, S., & Plückthun, A. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80073-6 · Cited by 114
Screening for Soluble Expression of Recombinant Proteins in a 96-Well Format
Knaust, R., & Nordlund, P. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5331 · Cited by 113
Lindner, P. J., Bauer, K., Krebber, A., Nieba, L., Kremmer, E., Krebber, C., Honegger, A., Klinger, B., Mocikat, R., & Plückthun, A. (1997) · BioTechniques · doi:10.2144/97221rr01 · Cited by 111
Sharon, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4814 · Cited by 101
Engineering Antibodies for Therapy
Presta, L. G. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378256 · Cited by 94
Jurado, P., de Lorenzo, V., & Fernández, L. Á. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.12.058 · Cited by 91
A simple vector system to improve performance and utilisation of recombinant antibodies
Martin, C. D., Rojas, G., Mitchell, J. N., Vincent, K. J., Wu, J., McCafferty, J., & Schofield, D. J. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-46 · Cited by 78
Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells
Li, X., Stuckert, P., Bosch, I., Marks, J. D., & Marasco, W. A. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700337 · Cited by 77
Beers, R., Chowdhury, P., Bigner, D. D., & Pastan, I. (2000) · PubMed · Cited by 75
Protein production in Escherichia coli for structural studies by X-ray crystallography
Goulding, C. W., & Perry, L. J. (2003) · Journal of Structural Biology · doi:10.1016/s1047-8477(03)00044-3 · Cited by 73
Tailor-made antibody therapeutics
Chowdhury, P. S., & Wu, H. (2005) · Methods · doi:10.1016/j.ymeth.2005.01.002 · Cited by 67
Hoess, R. H., Mack, A. J., Walton, H. L., & Reilly, T. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.2.724 · Cited by 63
Complement recruitment using bispecific diabodies
Kontermann, R. E., Wing, M. G., & Winter, G. P. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-629 · Cited by 63
Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression
Morino, K., Katsumi, H., Akahori, Y., Iba, Y., Shinohara, M., Ukai, Y., Kohara, Y., & Kurosawa, Y. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00462-8 · Cited by 63
Guo, J., Shangyou, Y., Li, L., Zhang, Y.-Z., Huang, J.-N., & Zhang, C. (2003) · Journal of Biotechnology · doi:10.1016/s0168-1656(03)00020-8 · Cited by 60
Griep, R. A., van Twisk, C., Kerschbaumer, R. J., Harper, K., Torrance, L., Himmler, G., van der Wolf, J. M., & Schots, A. (1999) · Protein Expression and Purification · doi:10.1006/prep.1999.1041 · Cited by 55
Luo, D., Mah, N., Krantz, M. J., Wilde, K., Wishart, D. S., Zhang, Y., Jacobs, F., & Martin, L. (1995) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124986 · Cited by 53
Introduction to Antibody Engineering and Phage Display
Watkins, N. A., & Ouwehand, W. H. (2000) · Vox Sanguinis · doi:10.1046/j.1423-0410.2000.7820072.x · Cited by 51
CDP-870 (certolizumab) in rheumatoid arthritis
Kaushik, V., & Moots, R. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.4.601 · Cited by 51
Production of Novel Recombinant Single-Domain Antibodies against Tandem Repeat Region of MUC1 Mucin
Rahbarizadeh, F., Rasaee, M. J., Moghadam, M. F., Allameh, A., & Sadroddiny, E. (2004) · Hybridoma and Hybridomics · doi:10.1089/1536859041224334 · Cited by 49
LeBœuf, R. D., Galin, F. S., Hollinger, S. K., Peiper, S. C., & Blalock, J. E. (1989) · Gene · doi:10.1016/0378-1119(89)90065-6 · Cited by 49
Current status of cancer therapy with radiolabeled monoclonal antibody
Oriuchi, N., Higuchi, T., Hanaoka, H., Iida, Y., & Endo, K. (2005) · Annals of Nuclear Medicine · doi:10.1007/bf03027399 · Cited by 47
Okada, T., Akada, M., Fujita, T., Iwata, T., Goto, Y., Kido, K., Okada, T., Matsuzaki, Y., Kobayashi, K., Matsuno, S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1206 · Cited by 42
Breast cancer: Risk factors, screening, and prevention
Gross, R. E. (2000) · Seminars in Oncology Nursing · doi:10.1053/sonc.2000.8110 · Cited by 40
Intracellular and cell surface displayed single-chain diabodies
Kontermann, R. E., & Müller, R. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00062-9 · Cited by 39
Design of Bacterial Vector Systems for the Production of Recombinant Proteins in Escherichia coli
Monteiro, G. A., Cabral, J. M. S., & Taipa, M. Â. (2004) · Journal of Microbiology and Biotechnology · Cited by 38
Routes to active proteins from transformed microorganisms
Büchner, J., & Rudolph, R. (1991) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(91)90077-i · Cited by 38
Non-repetitive single-chain Fv linkers selected by selectively infective phage (SIP) technology
Hennecke, F., Krebber, C., & Plückthun, A. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.5.405 · Cited by 37
Deng, X. K., Nesbit, L. A., & Morrow, K. J. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.4.587-595.2003 · Cited by 37
Oelschlaeger, P., Srikant-Iyer, S., Lange, S., Schmitt, J., & Schmid, R. D. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00290-7 · Cited by 36
Koido, S., Tanaka, Y., Tajiri, H., & Gong, J. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.12.035 · Cited by 33
Construction of a diabody (small recombinant bispecific antibody) using a refolding system
Takemura, S.-I., Asano, R., Tsumoto, K., et al. (2000) · Protein Engineering Design and Selection · doi:10.1093/protein/13.8.583 · Cited by 33
Hu, X., O’Dwyer, R., & Wall, J. G. (2005) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.05.018 · Cited by 31
Hemminki, A., Niemi, S., Hoffren, A. M., Hakalahti, L., Söderlund, H., & Takkinen, K. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.4.311 · Cited by 30
Lekkerkerker, A., & Logtenberg, T. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00140-4 · Cited by 29
Rogozin, I. B., Solovyov, V. V., & Kolchanov, N. A. (1991) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(91)90005-7 · Cited by 28
Luka, J., Arlen, P. M., & Bristol, A. (2010) · BioMed Research International · doi:10.1155/2011/934757 · Cited by 26
Hogrefe, H. H., Mullinax, R. L., Lovejoy, A. E., Hay, B. N., & Sorge, J. A. (1993) · Gene · doi:10.1016/0378-1119(93)90162-v · Cited by 24
Plückthun, A. (1991) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(91)90016-x · Cited by 23
Molecular cloning, expression and mutagenesis of an anti-insulin single chain Fv (scFv)
Lake, D. F., Lam, K. S., Peng, L. S., & Hersh, E. M. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90022-1 · Cited by 18
Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer
Tong, Q., Liu, K., Lu, X., Shu, X., & Wang, G. (2010) · BioMed Research International · doi:10.1155/2010/121094 · Cited by 17
Kim, M.-K., Jeong, H.-J., Kao, C.-H. K., et al. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00296-7 · Cited by 17
Sheikholvaezin, A., Sandström, P., Eriksson, D., Norgren, N., Riklund, K., & Stigbrand, T. I. (2006) · Hybridoma · doi:10.1089/hyb.2006.25.181 · Cited by 17
Tumor antigens and markers for breast and ovarian cancers
Ghadersohi, A. (2002) · Frontiers in bioscience · doi:10.2741/ghader · Cited by 11
Cited by
The making of bispecific antibodies
Brinkmann, U., & Kontermann, R. E. (2017) · mAbs · doi:10.1080/19420862.2016.1268307 · Cited by 923
The role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788
Nanoparticle-Based Immunochemical Biosensors and Assays: Recent Advances and Challenges
Farka, Z., Juřík, T., Kovář, D., Trnková, L., & Skládal, P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00037 · Cited by 694
Biosensors for Whole-Cell Bacterial Detection
Ahmed, A., Rushworth, J. V., Hirst, N. A., & Millner, P. A. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00120-13 · Cited by 666
Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 605
Metadata
- Authors
- Ahmad, Z. A., Yeap, S. K., Ali, A. M., Ho, W. Y., Alitheen, N. B. M., & Hamid, M.
- Venue
- Clinical and Developmental Immunology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-15
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- OpenAlex
- W2014158928
- Cited by
- 760
- References
- 111
- FWCI
- 22.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.